Company intelligence / Profile preview

Ruishi Technology

Pudong, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Ruishi Technology provides full lifecycle eye health management services with an emphasis on myopia prevention and control among children and adolescents. The company develops technologies, products, and approaches aimed at vision care. It has raised significant venture capital funding to expand its offerings across China. There are no disclosed clinical trial results as it does not develop pharmaceuticals but rather offers medical device-based solutions/services for vision correction/prevention.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Ruishi Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruishi Technology.

Explore the full profile